Dra. Teraiza Mesa R.,
El anticuerpo #aducanumab reduce las placas A- Beta de la enfermedad de #Alzehimer Bastante…
El anticuerpo #aducanumab reduce las placas A- Beta de la enfermedad de #Alzehimer Bastante…
http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
Alzheimere karşı yeni antikor ilaç http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
TIL a study involving 165 patients with Alzheimer's found that those treated with the highest dose of an antibody drug…
L'anticós aducanumab redueix les plaques Aβ en la malaltia d'Alzheimer.
The antibody aducanumab reduces Aβ plaques in Alzheimer’s…
#Alzheimer #AlzheimersAwareness antibody aducanumab https://t.co/Nvg3N7S6KG
SIAMO ALL'INVEROSIMILE Questo articolo, annuncia la scoperta di un farmaco capace di ridurre fino a far scomparire le placche…
Antibody Treatment for Alzheimer Disease: A New Hope
El aducanumab reduce las placas de…
Зовсім скоро можливо буде відстрочити хворобу Альцгеймера Можливо, люди зробили дуже важливий крок в сторону позбавлення від ст…
ONE HOUR CO-CURRICULAR…
One of our studies is getting even more accolades!! We are so happy to share that the monoclonal study drug aducanumab…
عقار جديد لعلاج الزهايمر.. احتلت الشركة الامريكية (بايوجين) "Biogen" عناوين الصحف في الولايات المتحدة بعد وصولها لنتائج مشجعة جد…
阿茲罕默症的新藥,由 Biogen 研發的抗體藥物 aducanumab。 這個研究之前已發表在 conference,這是第一次發表在 peer-reviewed paper。Biogen 研發的治療阿茲罕默症的抗體藥物 aducanumab (BIIP…
This Nature News
¡Excelente fin de semana a todos!
This Nature News
This Nature News
This Nature News
Experts are cautious about the breakthrough in Alzheimer's…
Big news! An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s…
Alzhéimer-Medicamentos Biogen está probando un anticuerpo que elimina placas amiloides del cerebro y que podría convertirse en…
Det her er ret vildt. Det er den første behandling nogensinde der faktisk kan revertere noget af den skade som Alzheimer's gør på…
Учёные тестируют новое лекарство от болезни Альцгеймера Снова это страшное словосочетание — "болезнь Альцгеймера". Считается, ч…
Alzheimer: un farmaco, nei test preliminari sull'uomo, ha mostrato la capacità di diminuire la quantità di placche amiloidi, l'ac…
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Bir antikor olan Aducanumab'ın Alzheimer hastalarının beyninde amiloid plaklarını azalttığı gösterildi. Henüz araştırma aşamasınd…
【阿茲海默症新藥】 阿茲海默症為失智的一種,常見的症狀為難保留新的記憶,譫妄,情緒改變/易怒,困惑等。阿茲海默症好發於65歲以上的老年人,病情會隨著時間逐漸惡化,而目前市面上並沒有藥物可以有效治療。但根據9月份的自然(Nature)期刊所發表的最新阿茲海默…
Імунотерапія змогла уповільнити прогресування хвороби Альцгеймера. Американські та швейцарські вчені повідомили про успіх ранніх…
Při prvním testu nového léku na Alzheimera došlo u pacientů k zastavení zhoršování stavu. Více o tom na níže uvedeném odkazu…
The antibody aducanumab was found to reduce toxic amyloid plaque in the brain. Toxic amyloid plaque buildup in the brain is…
PESQUISA - Atual. Anticorpos e a Doença de Alzheimer. http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
Aducanumab, una esperanza para la enfermedad de Alzheimer? BIIB037 es una anticuerpo humano monoclonal IgG1 de alta afinidad…
New Alzheimer's drug trial clears toxic brain proteins and slows memory loss. A new drug trial for Alzheimer’s patients has…
#medicina: pubblicati su Nature i risultati di un trial clinico sull’utilizzo di un anticorpo monoclonale in grado di ripulire…
florbetapir PETで、アミロイド除去が見事に検出されています。
😃
An antibody therapy that reduces amyloid beta deposits in the brains of patients with mild Alzheimer’s disease is reported in…
เราอาจได้เห็นยารักษาอัลไซเมอร์ได้จริง ๆ เสียที เดือนกันยายนของทุกปีได้รับการกำหนดให้เป็น World Alzheimer's Month เพื่อให้สาธารณช…
An antibody therapy that reduces amyloid beta deposits in the brains of patients with mild Alzheimer’s disease is reported in…
http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
A new drug trial has yielded promising results for the treatment of Alzheimer's Disease! Patients who suffer Alzheimer's…
After 1-year of transfusions with the human monoclonal antibody aducanumab, patients with mild cognitive impairment and…
An antibody therapy that reduces amyloid beta deposits in the brains of patients with mild Alzheimer’s disease is reported in…
#JuevesDeNature de Biblioteca CCG #Alzheimer
Encuentran un esperanzador fármaco contra el alzhéimer Parece ser que el medicamento puede eliminar las placas de la proteína…
An antibody therapy that reduces amyloid beta deposits in the brains of patients with mild Alzheimer’s disease is reported in…
𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡? An experimental drug swept sticky plaques from the brains of a small number of people with Alzheimer’s…
#JuevesDeNature The antibody aducanumab reduces Aβ plaques in #Alzheimer’s…
Not muscle related but fascinating! The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/CH3uPOLdD8
اخبار عظيمة جدا ...تحسين الحالة الذهنية و الادراكية للمرضي. بعد عشر سنين من البحث العلمي و العمل علي تطوير هذا المركب. http://www…
An antibody therapy that reduces amyloid beta deposits in the brains of patients with mild Alzheimer’s disease is reported in…
And they still try to deny it's medical benefits
#CienciaHoy El fármaco experimental aducanumab ha tenido resultados muy prometedores reduciendo los síntomas del Alzheimer, la…
Official lab report of the recent breakthroughs in Alzheimer's and Cannabis! A fascinating study which bonafide results…
An antibody therapy that reduces amyloid beta deposits in the brains of patients with mild Alzheimer’s disease is reported in…
http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
A new drug to treat alzheimer's disease has shown to be both safe in humans and help alleviate memory loss. The results showed…
01.09.2016 - http://www.bbc.com/news/health-37222863 Forscher der Universität Zürich und des Bioforschungsunternehmens Biogen…
Good news today in Nature: Biogen shows that aducanumab reduces Abeta plaques in Phase 1b trial! Hopefully, these results will…
“This is the best news we’ve had in my 25 years of doing #Alzheimer’s research... ” Nature paper: The antibody aducanumab…
هل وصل العلم الى مرحلة علاج خرف الزهايمر؟ فعالية العقاقير المتوفرة حاليا لعلاج الخرف ضعيفة على احسن تقدير او لا فعالية لها. ماذا…
From Eric Topol Looks like a major advance for #Alzheimerdisease; can't wait to read!